Comprehensive endocrine evaluation, including pituitary axis profiling, dynamic growth hormone testing, and assessments of insulin and leptin resistance, excluded secondary causes of obesity and reinforced the likelihood of a monogenic etiology. Here, GH1 is linked to obesity disorder.